AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$19.36
+0.94%Forward multiples
Based on analyst estimates
- P/E forward
- 17.82x
- P/E 2026E
- 18.82x
- P/E 2027E
- 16.16x
- P/E 2028E
- 13.27x
- P/S forward
- 1.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.91x
- PEG TTM
- 0.33x
- Price / book
- 187.22x
- Price / sales
- 1.98x
- Price / cash flow
- 30.79x
Enterprise value
- Enterprise value
- $8.9B
- EV / sales
- 2.86x
- EV / EBITDA
- 13.69x
- EV / EBIT
- 22.15x
- Market cap
- $6.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026